S-phase fraction as response marker in patients with chronic myeloid leukemia

Leuk Lymphoma. 2009 Jul;50(7):1223-5. doi: 10.1080/10428190902995663.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzamides
  • Biomarkers, Tumor / metabolism*
  • Case-Control Studies
  • DNA / metabolism
  • Drug Resistance, Neoplasm
  • Female
  • Flow Cytometry / methods*
  • Gene Expression Profiling
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
  • Male
  • Piperazines / pharmacology
  • Pyrimidines / pharmacology
  • RNA, Messenger / metabolism
  • S Phase*

Substances

  • Benzamides
  • Biomarkers, Tumor
  • Piperazines
  • Pyrimidines
  • RNA, Messenger
  • Imatinib Mesylate
  • DNA